SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT04181645 · COMPLETED
Trial details
- NCT number
- NCT04181645
- Sponsor
- RenJi Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-29
- Primary completion
- 2021-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.